These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 21254951)
1. Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review. Denis P Expert Opin Pharmacother; 2011 Feb; 12(3):463-71. PubMed ID: 21254951 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of monotherapy change to fixed combination (travoprost 0.004%/timolol 0.5%) in 6 months follow up period. Mandić Z; Novak-Laus K; Bojić L; Popović-Suić S; Ekert M; Dosen VM; Pelcić G; Clementi D; Dobutović D; Biuk D; Iveković R; Kovacić Z; Pavan J; Susić N; Geser MZ; Krolo I; Barisić F; Jurić-Miletić A; Dogan KK; Tomić M; Kovacević S Acta Clin Croat; 2010 Dec; 49(4):411-9. PubMed ID: 21830452 [TBL] [Abstract][Full Text] [Related]
3. Modern alchemy: fixed combinations of glaucoma drugs. Katz LJ Am J Ophthalmol; 2005 Jul; 140(1):125-6. PubMed ID: 16038653 [No Abstract] [Full Text] [Related]
4. Twenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma. Konstas AG; Mikropoulos D; Haidich AB; Ntampos KS; Stewart WC Br J Ophthalmol; 2009 Apr; 93(4):481-5. PubMed ID: 19019932 [TBL] [Abstract][Full Text] [Related]
5. A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertension. Hughes BA; Bacharach J; Craven ER; Kaback MB; Mallick S; Landry TA; Bergamini MV J Glaucoma; 2005 Oct; 14(5):392-9. PubMed ID: 16148589 [TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution. Barnebey HS; Orengo-Nania S; Flowers BE; Samples J; Mallick S; Landry TA; Bergamini MV Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081 [TBL] [Abstract][Full Text] [Related]
7. Comparison of evening and morning dosing of travoprost 0.004%/timolol 0.5% fixed combination in 6 month period. Suić SP; Laus KN; Dosen VM; Ekert M; Mandić Z; Bojić L Coll Antropol; 2010 Sep; 34(3):847-52. PubMed ID: 20977071 [TBL] [Abstract][Full Text] [Related]
8. Travoprost/timolol fixed combination. Herceg M; Noecker R Expert Opin Pharmacother; 2008 Apr; 9(6):1059-65. PubMed ID: 18377347 [TBL] [Abstract][Full Text] [Related]
9. Observational study of patients switched to the fixed travoprost 0.004%/timolol 0.5% combination in Croatia. Mandic Z; Novak-Lauš K; Bojic L; Popovic-Suic S; Maricic-Došen V; Pelcic G; Dobutovic D; Biuk D; Kovacic Z; Pavan J Methods Find Exp Clin Pharmacol; 2010 Oct; 32(8):593-8. PubMed ID: 21132129 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension. Schuman JS; Katz GJ; Lewis RA; Henry JC; Mallick S; Wells DT; Sullivan EK; Landry TA; Bergamini MV; Robertson SM Am J Ophthalmol; 2005 Aug; 140(2):242-50. PubMed ID: 16086946 [TBL] [Abstract][Full Text] [Related]
11. Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%. Scherzer ML; Liehneova I; Negrete FJ; Schnober D Adv Ther; 2011 Aug; 28(8):661-70. PubMed ID: 21773673 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of intraocular pressure lowering efficacy of bimatoprost / timolol fixed combination and other glaucoma medications in the treatment of glaucoma]. Skorkovská K Cesk Slov Oftalmol; 2008 Jul; 64(4):144-8. PubMed ID: 18780653 [TBL] [Abstract][Full Text] [Related]
13. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448 [TBL] [Abstract][Full Text] [Related]
14. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma. Holló G; Kóthy P Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590 [TBL] [Abstract][Full Text] [Related]
15. 24-Hour intraocular pressure control between travoprost/timolol fixed combination, latanoprost/ timolol fixed combination and standard timolol in primary open angle glaucoma and ocular hypertension. Pachimkul P; Yuttitham K; Thoophom P J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S81-7. PubMed ID: 21717884 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination. Centofanti M; Oddone F; Gandolfi S; Hommer A; Boehm A; Tanga L; Sangermani C; Sportelli V; Haustein M; Manni G; Rossetti L Am J Ophthalmol; 2010 Oct; 150(4):575-80. PubMed ID: 20688314 [TBL] [Abstract][Full Text] [Related]
17. Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy. Goldberg I; Crowston JG; Jasek MC; Stewart JA; Stewart WC; J Glaucoma; 2012 Jan; 21(1):55-9. PubMed ID: 21048504 [TBL] [Abstract][Full Text] [Related]